Edition:
India

Aptargroup Inc (ATR.N)

ATR.N on New York Stock Exchange

117.66USD
6 Aug 2020
Change (% chg)

$-0.70 (-0.59%)
Prev Close
$118.36
Open
$118.30
Day's High
$119.00
Day's Low
$116.74
Volume
68,313
Avg. Vol
108,468
52-wk High
$124.00
52-wk Low
$79.84

Summary

Name Age Since Current Position

George Fotiades

66 2018 Independent Non-Executive Chairman of the Board

Stephan Tanda

55 2017 President, Chief Executive Officer, Director

Robert Kuhn

57 2011 Chief Financial Officer, Executive Vice President, Secretary

Xiangwei Gong

50 2018 President - Aptar Asia

Marc Prieur

54 2019 President - Aptar Beauty + Home

Heidi Tlili

45 2019 President - Aptar Food + Beverage

Gael Touya

50 2018 President - Aptar Pharma

Shiela Vinczeller

56 2018 Chief Human Resource Officer

Eldon Schaffer

54 2019 Executive Vice President - Strategic Projects and Commercial Excellence

Giovanna Kampouri Monnas

64 2010 Independent Director

Andreas Kramvis

67 2014 Independent Director

Isabel Marey-Semper

52 2019 Independent Director

Maritza Montiel

68 2015 Independent Director

B. Craig Owens

65 2018 Independent Director

Joanne Smith

59 1999 Independent Director

Jesse Wu

63 2018 Independent Director

Ralf Wunderlich

53 2009 Independent Director

Biographies

Name Description

George Fotiades

Mr. George L. Fotiades serves as Independent Non-Executive Chairman of the Board of the Company. Mr. Fotiades has been Chairman of the Board since 2018. Mr. Fotiades has been President and CEO of Cantel Medical Corp. (NYSE-listed manufacturer of infection prevention and control products) since March 2019. He was Operating Partner at Five Arrows Capital Partners (Rothschild Merchant Banking) from April 2017 until March 2019. From 2007 through April 2017, he was Chairman and Operating Partner of Healthcare Investments at Diamond Castle Holdings LLC (private equity investing). He is a director of the following NYSE-listed companies: Prologis, Inc. (integrated distribution facilities and services) and Cantel Medical Corp. The Board of Directors concluded that Mr. Fotiades should continue to serve as a director of Aptar due to his extensive experience from previously held senior executive positions at leading healthcare and consumer product companies including Cardinal Health, Inc., Catalent Pharma Solutions, the former Warner-Lambert’s Consumer Health Products Group (now part of Johnson & Johnson) and Bristol-Myers Squibb’s Consumer Products, Japan division. The Board also considered his present and past board level experience with global organizations.

Stephan Tanda

Mr. Stephan B. Tanda serves as President, Chief Executive Officer, Director of the Company. Mr. Tanda became President and Chief Executive Officer of Aptar on February 1, 2017. Prior to this, Mr. Tanda served from 2007 until 2017 as an Executive Managing Board Director at Royal DSM NV (leading global supplier of ingredients and material solutions for the food, dietary supplement, personal care, medical device, automotive, paint, electronic and bio-material markets), where he was responsible for DSM’s Nutrition and Pharma activities, as well as DSM’s presence in the Americas and various corporate duties. Mr. Tanda is a director of Ingredion Incorporated (a NYSE-listed global supplier of high-quality food and industrial ingredient solutions). Mr. Tanda was a director of Patheon NV (formerly a NYSE-listed company that provided pharmaceutical development and manufacturing services) from March 2016 until the company was sold to Thermo Fisher Scientific in August 2017.

Robert Kuhn

Mr. Robert W. Kuhn serves as Chief Financial Officer, Executive Vice President, Secretary of the Company. Mr. Kuhn has been Executive Vice President and Chief Financial Officer since September 2008. Mr. Kuhn has been Secretary since June 2011. Prior to this, Mr. Kuhn was Vice President Financial Reporting from 2000 to 2008.

Xiangwei Gong

Ms. Xiangwei Gong serves as President - Aptar Asia of the Company. Ms. Gong has been President of Aptar Asia since October 2018. Prior to this, Ms. Gong held various leadership positions at Royal DSM for over 22 years. She was President of DSM Hydrocolloids from 2014 to 2018, President Asia of DSM Food Specialties from 2011 to 2014, Vice President of Channel Marketing from 2008 to 2011 and Vice President of Personal Care in DSM North America from 2005 to 2008.

Marc Prieur

Mr. Marc Prieur serves as President - Aptar Beauty + Home of the Company. Mr. Prieur has been President of Aptar Beauty + Home since December 2019. Prior to this, Mr. Prieur was President of Aptar Food + Beverage from September 2018 to November 2019, VP of Aptar Operational Excellence from June 2017 to August 2018, President EMEA Sales & Operations – Consumer Health Care from June 2013 to June 2017 and President of our Pharma business in Asia from June 2008 to June 2013.

Heidi Tlili

Mr. Heidi Tlili serves as President - Aptar Food + Beverage of the Company. Mr. Tlili has been President of Aptar Food + Beverage since December 2019. Prior to this, Mr. Tlili was President of Aptar EMEA Beauty + Home from June 2018 to November 2019 and President of Aptar EMEA Food + Beverage from May 2016 to May 2018. Prior to joining Aptar, Mr. Tlili held leadership positions at our packaging solutions peers Albéa and Sonoco. He was a Cluster Deputy Manager in Albéa Group from September 2014 to March 2016, Country General Manager in Sonoco from April 2013 to June 2014 and European Sales and Marketing Director from September 2011 to March 2013 in Sonoco.

Gael Touya

Mr. Gael Touya is President - Aptar Pharma of the Company. Mr. Touya has been President of Aptar Pharma since September 2018. Prior to this, Mr. Touya was President of Aptar Food + Beverage from 2016 to August 2018, President of Aptar Food + Beverage Europe from 2012 to 2015 and Business Development Vice President Skin Care and Color Cosmetics from 2010 to 2011.

Shiela Vinczeller

Ms. Shiela Pallerne Vinczeller serves as Chief Human Resource Officer of the Company. Shiela is a seasoned, senior Human Resources executive with over 25 years of global leadership experience. She brings to Aptar a strong track record of global talent management with deep experience in Diversity and Inclusion and a sharp focus on building effective teams. Prior to joining Aptar, Shiela spent 12 years in Human Resources leadership roles at International Paper, one of the world's leading producers of fiber-based packaging, pulp and paper. Shiela holds a Post Graduate Degree in Marketing Communication and a degree in International Business from the Budapest Business School. Shiela serves as the President of the Board of Directors for the Germantown Performing Arts Center in Tennessee and is a member of the Board of Directors for Leadership Memphis.

Eldon Schaffer

Mr. Eldon W. Schaffer II serves as Executive Vice President - Strategic Projects and Commercial Excellence of the Company. he was President of Aptar Beauty and Home of the Company. Prior to this, Mr. Schaffer was President of Aptar Food and Beverage from 2012 to 2015 and President of Aptar Beauty and Home North America from 2010 to 2011.

Giovanna Kampouri Monnas

Ms. Giovanna Kampouri Monnas serves as Independent Director of the Company. Ms. Kampouri Monnas is an advisor and serves on the boards of several global companies. Since 2019, she is Chairman of Exea Ventures BV in the Netherlands, a global family investment company with diverse holdings in fragrances, fashion, skin care, real estate and venture funds. Ms. Kampouri Monnas is also a director of Puig S.L. (a fashion and fragrance business). From 2006 to 2018, Ms. Kampouri Monnas was a member of the supervisory board and Chairman of the Compensation Committee of Randstad Holding NV (a Euronext-listed provider of human resource services based in Amsterdam). From 2015 to 2018, Ms. Kampouri Monnas was a director of Imerys S.A. (a Euronext-listed producer of industrial minerals, based in France). Her final executive role was President of Benckiser International.

Andreas Kramvis

Mr. Andreas C. Kramvis is an Independent Director of the Company. Mr. Kramvis is an operating partner at AEA Investors (a private equity firm). Mr. Kramvis was Vice Chairman of Honeywell International (a multi-industry company with presence in Aerospace, Automation and Controls, Chemicals and Automotive Industries) from April 2014 to February 2017. From 2008 to 2014, Mr. Kramvis was President and Chief Executive Officer of the Honeywell Performance Materials and Technologies group (a developer of processes and chemicals for oil refining, petrochemicals and a variety of high-purity, high-quality performance chemicals and materials). Mr. Kramvis is also a director of several privately-held companies. From 2014 to 2019, Mr. Kramvis was a director of Axalta Coating Systems Ltd. (a NYSE-listed developer, manufacturer and seller of liquid and powder coatings).

Isabel Marey-Semper

Ms. Isabel Marey-Semper serves as Independent Director of the Company. Ms. Marey-Semper was a member of the Executive Committee of L’Oréal S.A. (personal care company and world’s largest cosmetic company), in charge of Communications and Public Affairs, from July 2015 to December 2017. Prior to this, Ms. Marey-Semper served from 2011 to 2015 as Vice President and Head, Advanced Research at L’Oréal. Prior to joining L’Oréal, Ms. Marey-Semper served in executive positions at established industrial companies such as Compagnie de Saint Gobain S.A. (a Euronext-listed French multinational manufacturer and distributor of building materials) and Group PSA Peugeot Citroën (a Euronext-listed French multinational manufacturer of automobiles and motorcycles). Ms. Marey-Semper is a director of the Imagine Institute (institute for medical research and treatment of genetic diseases), the Inria Foundation (research foundation dedicated to digital science and technology) and Damae Medical (a medical company focused on diagnosing skin tumors without the need for a biopsy). Ms. Marey-Semper was a director of Rexel (a Euronext listed French distributor of electrical supplies) from 2014 to 2016.

Maritza Montiel

Ms. Maritza Gomez Montiel serves as Independent Director of the Company. Ms. Montiel served as Deputy Chief Executive Officer and Vice Chairman of Deloitte LLP from 2011 through her retirement in May 2014. During Ms. Montiel’s tenure at Deloitte, she was the Advisory Partner for many engagements in which Deloitte was the principal auditor. Ms. Montiel has over 30 years of experience in leading and performing audits of various entities. Ms. Montiel is a director of McCormick & Company, Inc. (a NYSE-listed spice, herb and flavoring manufacturer); Royal Caribbean Cruises Ltd. (a NYSE-listed global cruise company) and Comcast Corporation (a Nasdaq-listed telecommunications company).

B. Craig Owens

Mr. B. Craig Owens is an Independent Director of the Company. Mr. Owens was the Chief Financial Officer and Chief Administrative Officer of Campbell Soup Company (global producer and seller of canned soups and related products) from 2008 through 2014. Mr. Owens is a director of J. C. Penney Company, Inc. (a NYSE-listed U.S. department store chain), Dean Foods Company (a NYSE-listed U.S. food and beverage company) and Crown Holdings, Inc. (a NYSE-listed designer, manufacturer and seller of packaging products and equipment for consumer goods and industrial products).

Joanne Smith

Dr. Joanne C. Smith, M.D. is an Independent Director of the Company. Dr. Smith is a physician at the Shirley Ryan AbilityLab (formerly the Rehabilitation Institute of Chicago) and became the Shirley Ryan AbilityLab’s President and Chief Executive Officer in 2006. Dr. Smith is a director of Performance Health, Inc. (rehabilitation and wellness products manufacturer). From 2003 to 2015, Dr. Smith was a director of Hill-Rom, Inc. (a NYSE-listed healthcare and medical technology, formerly Hillenbrand Industries).

Jesse Wu

Mr. Jesse Wu is an Independent Director of the Company . Mr. Wu is an advisor to private equity firms. From 2003 through 2016, Mr. Wu held senior leadership roles at Johnson & Johnson (multinational medical devices, pharmaceutical and consumer packaged goods manufacturing company) including Chairman of Johnson & Johnson China and Worldwide Chairman of the company’s Consumer Healthcare Division. Mr. Wu is a director of The a2 Milk Company Limited (an ASX- and NZX-listed company that commercializes intellectual property relating to a2 milk and related products) and Shanghai Kehua Bio-Engineering Co. Ltd. (a SZSE-listed manufacturer of in vitro diagnostic products). Mr. Wu was a director of Li-Ning Company Limited (an HKSE-listed athletic shoes and sporting goods company) from August 2015 until March 2018.

Ralf Wunderlich

Mr. Ralf Klaus Wunderlich is an Independent Director of the Company. Mr. Wunderlich is an advisor and operating partner to several private equity companies. He was a member of Amcor Limited’s Global Executive Team and was President of the business group Amcor Flexibles Asia Pacific (packaging solutions) from 2010 to 2016. Mr. Wunderlich was a director of AMVIG Holdings Limited (a SEHK-listed cigarette packaging and printing company) from 2010 to 2015. Mr. Wunderlich is a director of Essentra PLC (a LSE-listed supplier of plastic and fibre products) and Huhtamaki Oyj (a Nasdaq Helsinki-listed global food packaging company).

Basic Compensation